Novartis Wants To Bar United States From Using ‘Markers’ In Fraud Case
NEW YORK — Novartis Pharmaceuticals Corp. (NPC) on March 14 asked a federal court to conduct a pre-motion conference, saying it wants partial summary judgment preventing the United States from using...To view the full article, register now.
Already a subscriber? Click here to view full article